|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 |
| (11) | Patento numeris | 2524231 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11700467.1 |
| Europos patento paraiškos padavimo data | 2011-01-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-11-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-06-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/020080 |
| Data | 2011-01-04 |
| (87) | Numeris | WO 2011/087926 |
| Data | 2011-07-21 |
| (30) | Numeris | Data | Šalis |
| 294615 P | 2010-01-13 | US |
| (72) |
COUGHLIN, Christina Marie, US
BERKENBLIT, Anna, US
FEINGOLD, Jay Marshall, US
JOHNSTON, Daniel Stephen, US
STRAHS, Andrew Louis, US
ZACHARCHUK, Charles Michael, US
|
| (73) |
Wyeth LLC,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | A CUT-POINT IN PTEN PROTEIN EXPRESSION THAT ACCURATELY IDENTIFIES TUMORS AND IS PREDICTIVE OF DRUG RESPONSE TO A PAN-ErbB INHIBITOR |
| A CUT-POINT IN PTEN PROTEIN EXPRESSION THAT ACCURATELY IDENTIFIES TUMORS AND IS PREDICTIVE OF DRUG RESPONSE TO A PAN-ErbB INHIBITOR |